Family history
Revise how to take a three-generation family history, identify first- and second-degree relatives, age at diagnosis and clustering of cancer or inherited disease.
These questions test how genomics appears in primary care: family history, inherited cancer risk, rare disease clues, testing decisions, consent and safe referral into NHS pathways.
For AKT genomic medicine, prioritise family history, inheritance patterns, familial cancer clues, rare disease red flags, consent for genomic testing, referral thresholds and how to handle uncertainty or direct-to-consumer results safely.
Revise how to take a three-generation family history, identify first- and second-degree relatives, age at diagnosis and clustering of cancer or inherited disease.
Know autosomal dominant, autosomal recessive, X-linked, mitochondrial and multifactorial inheritance well enough to interpret common AKT pedigrees.
Focus on breast, ovarian, bowel, prostate and pancreatic cancer patterns, early onset, bilateral disease and when family history should trigger specialist assessment.
Look for multisystem features, developmental delay, dysmorphism, unexplained recurrent problems, consanguinity and repeated family events.
Understand that genomic testing affects relatives, needs informed consent, may produce uncertain results and is usually coordinated through specialist pathways.
GPs identify risk, explain uncertainty, refer appropriately, support long-term care and respond safely to direct-to-consumer or incidental genomic information.
The trap is expecting molecular detail. AKT genomic medicine is usually about practical primary care: spotting a pattern, taking the right family history, explaining uncertainty, considering relatives and referring through the right NHS pathway.
Yes. Genomic medicine is an RCGP curriculum topic. AKT questions can test family history, inheritance patterns, familial cancer risk, rare disease clues, genomic testing, consent, referral routes and primary care follow-up.
Start with family-history taking, first- and second-degree relatives, inheritance patterns, familial breast or bowel cancer clues, rare disease red flags, genetic testing consent and when to refer to specialist services.
They often appear as ordinary GP consultations: a patient worried about family cancer, a child with developmental features, a direct-to-consumer DNA result, a medicine affected by genetics or a family needing referral advice.
Usually no. The AKT is more likely to test practical primary care decisions: family history, pattern recognition, consent, uncertainty, referral and safe explanation of genetic or genomic risk.
This is revision guidance, not official RCGP advice. Check current RCGP, NHS, NICE, local genomic-medicine pathways and specialist advice for clinical decisions. Last reviewed June 2026.
Questions, mocks and explanations are free. Your first 2 hours of AKT audio are free. Full 4-month audio access is £79.